Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LERCANIDIPINE: 3,767 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
3,767
Total FAERS Reports
248 (6.6%)
Deaths Reported
2,249
Hospitalizations
3,767
As Primary/Secondary Suspect
396
Life-Threatening
39
Disabilities

First Report: 2000 · Latest Report: 20250909

What Are the Most Common LERCANIDIPINE Side Effects?

#1 Most Reported
Acute kidney injury
424 reports (11.3%)
#2 Most Reported
Hypotension
401 reports (10.6%)
#3 Most Reported
Fall
323 reports (8.6%)

All LERCANIDIPINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Acute kidney injury 424 11.3% 21 339
Hypotension 401 10.7% 19 325
Fall 323 8.6% 12 299
Hypertension 197 5.2% 2 75
Hyperkalaemia 176 4.7% 3 78
Drug ineffective 149 4.0% 1 90
Diarrhoea 122 3.2% 14 102
Hyponatraemia 122 3.2% 1 113
Renal impairment 120 3.2% 0 50
Oedema peripheral 114 3.0% 0 69
Syncope 114 3.0% 1 101
Asthenia 112 3.0% 1 77
Coma 112 3.0% 26 38
Bradycardia 109 2.9% 9 75
Dizziness 105 2.8% 1 80
Off label use 105 2.8% 9 56
Fatigue 104 2.8% 2 30
Overdose 103 2.7% 1 56
Abdominal pain 102 2.7% 0 39
Dyspnoea 97 2.6% 15 55

Who Reports LERCANIDIPINE Side Effects? Age & Gender Data

Gender: 47.8% female, 52.2% male. Average age: 65.8 years. Most reports from: FR. View detailed demographics →

Is LERCANIDIPINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 13 0 9
2005 1 0 1
2006 5 2 4
2007 10 0 3
2008 4 0 0
2009 4 0 2
2010 14 0 1
2011 12 0 4
2012 29 1 15
2013 25 3 20
2014 116 3 51
2015 143 9 118
2016 149 7 111
2017 241 13 147
2018 488 28 365
2019 396 37 233
2020 361 30 170
2021 221 21 106
2022 183 21 120
2023 174 12 99
2024 235 27 148
2025 48 11 32

View full timeline →

What Is LERCANIDIPINE Used For?

IndicationReports
Hypertension 2,075
Product used for unknown indication 1,155
Poisoning deliberate 37
Myocardial ischaemia 22
Essential hypertension 14
Toxicity to various agents 14
Blood cholesterol increased 12
Hypercholesterolaemia 11
Medication error 11
Atrial fibrillation 10

LERCANIDIPINE vs Alternatives: Which Is Safer?

LERCANIDIPINE vs LETAIRIS LERCANIDIPINE vs LETERMOVIR LERCANIDIPINE vs LETROZOLE LERCANIDIPINE vs LETROZOLE\RIBOCICLIB LERCANIDIPINE vs LEUCOVORIN LERCANIDIPINE vs LEUCOVORIN\LEUCOVORIN LERCANIDIPINE vs LEUPROLIDE LERCANIDIPINE vs LEVALBUTEROL LERCANIDIPINE vs LEVAMISOLE LERCANIDIPINE vs LEVAQUIN

Official FDA Label for LERCANIDIPINE

Official prescribing information from the FDA-approved drug label.